![Immunohistochemistry-Paraffin: GPR110 Antibody [NLS2021] - Analysis of anti-GPR110 antibody with human breast, carcinoma.](http://images.novusbio.com/fullsize/GPR110-Antibody-Immunohistochemistry-Paraffin-NLS2021-img0002.jpg "Immunohistochemistry-Paraffin: GPR110 Antibody [NLS2021] - Analysis of anti-GPR110 antibody with human breast, carcinoma.")
| Reactivity | Hu, PmSpecies Glossary |
| Applications | IHC |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Format | BSA Free |
| Concentration | 1.0 mg/ml |
| Description | Product can be stored undiluted at 4C for up to 1 month. |
| Immunogen | Synthetic 17 amino acid peptide from N-terminal extracellular domain of human GPR110. |
| Epitope | N-terminal extracellular domain of human |
| Specificity | Human GPR110. BLAST analysis of the peptide immunogen showed no homology with other human proteins. |
| Predicted Species | Primate (100%). Backed by our 100% Guarantee. |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | ADGRF1 |
| Purity | Immunogen affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Storage | Keep as concentrated solution. Aliquot and store at -20C or below. Avoid multiple freeze-thaw cycles. |
| Buffer | PBS |
| Preservative | 0.1% Sodium Azide |
| Concentration | 1.0 mg/ml |
| Purity | Immunogen affinity purified |
![Flow Cytometry EMR3 Antibody (908235) [Unconjugated]](https://images.novusbio.com/images2/EMR3_MAB8496_Flow_Cytometry_16807.jpg)
![Immunohistochemistry EMR3 Antibody (908235) [Unconjugated]](https://images.novusbio.com/images2/mab8496_human-emr3-mab-clone-908235-immunohistochemistry-2852021145344.jpg)
Secondary Antibodies |
Isotype Controls |
Research Areas for GPR110 Antibody (NLS2021)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![Immunohistochemistry-Paraffin: GPR110 Antibody [NLS2021] - Analysis of anti-GPR110 antibody with kidney, renal tubules](http://images.novusbio.com/fullsize/GPR110-Antibody-Immunohistochemistry-Paraffin-NLS2021-img0001.jpg "Immunohistochemistry-Paraffin: GPR110 Antibody [NLS2021] - Analysis of anti-GPR110 antibody with kidney, renal tubules")
![Western Blot GPR56 Antibody [Unconjugated]](https://images.novusbio.com/images2/GPR56_AF4634_Western_Blot_11569.jpg)
![Simple Western GPR56 Antibody [Unconjugated]](https://images.novusbio.com/images2/GPR56_AF4634_Simple_Western_22172.jpg)
![Flow Cytometry GPR56 Antibody [Unconjugated]](https://images.novusbio.com/images2/GPR56_AF4634_Flow_Cytometry_12104.jpg)
![Flow Cytometry GPR64 Antibody [Unconjugated]](https://images.novusbio.com/images2/GPR64_AF7977_Flow_Cytometry_22399.jpg)
![Western Blot GPR64 Antibody [Unconjugated]](https://images.novusbio.com/images2/GPR64_AF7977_Western_Blot_13069.jpg)
![Immunohistochemistry GPR64 Antibody [Unconjugated]](https://images.novusbio.com/images2/GPR64_AF7977_Immunohistochemistry_13077.jpg)
![Western Blot Ikaros/IKZF1 Antibody [Unconjugated]](https://images.novusbio.com/images2/Ikaros_AF4984_Western_Blot_5594.jpg)
![Chromatin Immunoprecipitation (ChIP) Ikaros/IKZF1 Antibody [Unconjugated]](https://images.novusbio.com/images2/Ikaros_AF4984_Chromatin_Immunoprecipitation_11241.jpg)
![Simple Western Ikaros/IKZF1 Antibody [Unconjugated]](https://images.novusbio.com/images2/Ikaros_AF4984_Simple_Western_16946.jpg)
![Flow Cytometry MICL/CLEC12A Antibody [Unconjugated]](https://images.novusbio.com/images2/MICL_AF2950_Flow_Cytometry_10876.jpg)
![Immunocytochemistry MICL/CLEC12A Antibody [Unconjugated]](https://images.novusbio.com/images2/MICL_AF2950_Immunocytochemistry__Immunofluorescence_17389.jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")